Clinical Trial Update: Valbenazine Treatment of Tardive Dyskinesia in Adults With Intellectual/Developmental Disabilities [Phase 4]

View source ↗

Summary

Phase 4 trial of valbenazine for tardive dyskinesia in adults with intellectual/developmental disabilities has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Developmental Disabilities
• Intellectual Disability
• Tardive Dyskinesia

Drugs mentioned

• Valbenazine (Ingrezza) (valbenazine)

Snippet

Sponsor: Stephen Ruedrich | Conditions: Tardive Dyskinesia, Intellectual Disability | Phase 4 | Status: WITHDRAWN